XenoSite

Azilsartan medoxomil anion

CHEBI
Phase 1ReactivityEpoxidationQuinonationN-DealkylationUGT Conjugation
Azilsartan medoxomil anion Quinonation prediction
CCOc1nc2c(n1Cc1ccc(-c3ccccc3-c3noc(=O)[n-]3)cc1)=C(C(=O)OCc1oc(=O)oc1C)C(=O)C(=O)C=2 Epoxidation prediction
CCOc1nc2c(n1Cc1ccc(-c3ccccc3-c3noc(=O)[n-]3)cc1)=C(C(=O)OCC13OC(=O)OC1(C)O3)C(=O)C(=O)C=2 stable oxygenation prediction
CCOc1nc2c(n1Cc1ccc(-c3ccccc3-c3noc(=O)[n-]3)cc1)=C(C(=O)OCC13OC(=O)OC1(C)O3)C(=O)C(=O)C=2 unstable oxygenation prediction
CCOc1nc2c(n1Cc1ccc(-c3ccccc3-c3noc(=O)[n-]3)cc1)=C(C(=O)OCC13OC(=O)OC1(C)O3)C(=O)C(=O)C=2 dehydrogenation prediction
CCOc1nc2c(n1Cc1ccc(-c3ccccc3-c3noc(=O)[n-]3)cc1)=C(C(=O)OCC13OC(=O)OC1(C)O3)C(=O)C(=O)C=2 reduction prediction
CCOc1nc2c(n1Cc1ccc(-c3ccccc3-c3noc(=O)[n-]3)cc1)=C(C(=O)OCC13OC(=O)OC1(C)O3)C(=O)C(=O)C=2 hydrolysis prediction
hydrolysis · 0.27
CCOc1nc2c(n1Cc1ccc(-c3ccccc3-c3noc(=O)[n-]3)cc1)=C(C(=O)OCC1(OC(=O)O)OC1(C)O)C(=O)C(=O)C=2
Probability scale from 0.0 to 1.0